1. Dadabhai S, Chou VB, Pinilla M, Chinula L, et al.
   Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial.
   AIDS 2024.
   


2. Patel D, Beer L, Yuan X, Tie Y, et al.
   Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men.
   AIDS 2024.
   


3. Himelhoch SS, Shuter J.
   Authors' response to 'Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment'.
   AIDS 2024;38:614.
   


4. Daungsupawong H, Wiwanitkit V.
   Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment.
   AIDS 2024;38:613.
   


5. Dickson S, James K.
   Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance.
   AIDS 2024;38:610-612.
   


6. VanderVeen LA, Selzer L, Moldt B, Parvangada A, et al.
   HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.
   AIDS 2024;38:607-610.
   


7. Lee D, Capeau J.
   Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
   AIDS 2024;38:603-605.
   


8. Zaccarelli M.
   Reassessing the emphasis on limited options in antiretroviral treatment.
   AIDS 2024;38:599-601.
   


9. Winston A, Price P.
   Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?
   AIDS 2024;38:597-598.
   


10. Mascolo S, Romanelli A.
    A new frontier in HIV care: the predictive power of renal biomarkers on heart health.
    AIDS 2024;38:595-596.
    


11. Wilson IB, Cole MB, Lee Y, Shireman TI, et al.
    The relationship of age and comorbid conditions to hospital and nursing home days in Medicaid recipients with HIV.
    AIDS 2024.
    


12. Wiseman RL, Bigos KL, Dastgheyb RM, Barker PB, et al.
    Brain N-acetyl-aspartyl-glutamate (NAAG) is associated with cognitive function in older virally-suppressed people with HIV.
    AIDS 2024.
    


13. Shivakoti R, Giganti MJ, Lederman MM, Ketchum R, et al.
    Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery.
    AIDS 2024.
    


14. Geng H, Liu B, Liu Y, Chen S, et al.
    Identification of the near full-length genome of a novel HIV-1 CRF01_AE/CRF07_BC recombinant in Hebei Province, China.
    AIDS Res Hum Retroviruses 2024.
    


15. Crocker-Buque T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al.
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis 2024.
    


16. Teixeira LAA, Santos B, Correia MG, Valiquette C, et al.
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis 2024.
    


17. Saldana CS, Burkhardt E, Pennisi A, Oliver K, et al.
    Development of a Machine Learning Modelling Tool for Predicting HIV Incidence Using Public Health Data from a County in the Southern United States.
    Clin Infect Dis 2024.
    


18. Marrazzo J, Tao L, Becker M, Leech AA, et al.
    HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
    JAMA 2024.
    


19. Sax PE, Thompson MA, Saag MS.
    Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel.
    JAMA 2024.
    


20. Hanley S, Moodley D, Naidoo M, Brummel SS, et al.
    THE IMPACT OF REGULAR SCREENING AND LIFESTYLE MODIFICATION ON CARDIOVASCULAR DISEASE RISK FACTORS IN SOUTH AFRICAN WOMEN LIVING WITH HIV.
    J Acquir Immune Defic Syndr 2024.
    


21. Oboho IK, Esber AL, Dear N, Paulin HN, et al.
    Advanced HIV Disease in East Africa and Nigeria, in The African Cohort Study (AFRICOS).
    J Acquir Immune Defic Syndr 2024.
    


22. Ben Farhat J, TiendrebeogoMD T, Malateste K, Poda A, et al.
    Effects of the Covid-19 pandemic on ART initiation and access to HIV viral load monitoring in adults living with HIV in West Africa: a regression discontinuity analysis.
    J Acquir Immune Defic Syndr 2024.
    


23. Tanaka T, Oshima K, Kawano K, Tashiro M, et al.
    Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999-2021: Trend in Non-AIDS-Defining Cancers Among HIV-1-Infected Individuals.
    J Acquir Immune Defic Syndr 2024.
    


24. Kennedy CE, Yeh PT, Verster A, Luhmann N, et al.
    Do Peer Navigators Improve Initiation and Retention in HIV/VH/STI Treatment Programs for People From Key Populations? A Systematic Review of Effectiveness, Values and Preferences, and Cost.
    J Acquir Immune Defic Syndr 2024;95:305-312.
    


25. Volk JE, Leyden WA, Lea AN, Lee C, et al.
    Using Electronic Health Records to Improve HIV Preexposure Prophylaxis Care: A Randomized Trial.
    J Acquir Immune Defic Syndr 2024;95:362-369.
    


26. France AM, Panneer N, Farnham PG, Oster AM, et al.
    Simulation of Full HIV Cluster Networks in a Nationally Representative Model Indicates Intervention Opportunities.
    J Acquir Immune Defic Syndr 2024;95:355-361.
    


27. Logan NZ, Kilmarx PH, Rolle I, Patel HK, et al.
    Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018.
    J Acquir Immune Defic Syndr 2024;95:313-317.
    


28. Opsteen S, Fram T, Files JK, Levitan EB, et al.
    Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.
    J Acquir Immune Defic Syndr 2024.
    


29. Calza L, Giglia M, Viale P.
    Relationship Between Vitamin D Deficiency and Nonalcoholic Fatty Liver Disease in Patients With HIV-1 Infection.
    J Acquir Immune Defic Syndr 2024;95:e5-e7.
    


30. McCrary AW, Hung F, Foster MC, Koech M, et al.
    Letter to the Editor: Cardiac Dysfunction Among Youth With Perinatal HIV Acquisition and Exposure.
    J Acquir Immune Defic Syndr 2024;95:e2-e4.
    


31. Nabukalu D, Yiannoutsos CT, Semeere A, Musick BS, et al.
    Mortality Among HIV-Infected Adults on Antiretroviral Therapy in Southern Uganda.
    J Acquir Immune Defic Syndr 2024;95:268-274.
    


32. van Heerden JK, Meintjes G, Barr D, Zhao Y, et al.
    Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr 2024;95:260-267.
    


33. Ngumbau NM, Neary J, Wagner AD, Abuna F, et al.
    Cofactors of Partner HIV Self-testing and Oral PrEP Acceptance Among Pregnant Women at High Risk of HIV in Kenya.
    J Acquir Immune Defic Syndr 2024;95:238-245.
    


34. Xiao G, Huang W, Zhong Y, Ou M, et al.
    Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection.
    J Infect Dis 2024.
    


35. Collazos J, Asensi V.
    Non-invasive liver fibrosis markers in the evaluation of fibrosis regression after direct-acting antiviral (DAA) therapy.
    J Infect Dis 2024.
    


36. Xiao J, Luo Y, Li Y, Yao X, et al.
    The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.
    J Med Virol 2024;96:e29488.
    


37. Joshi VR, Claiborne DT, Pack ML, Power KA, et al.
    A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
    J Virol 2024.
    


38. Randolph SD, Johnson R.
    A Salon-Based Intervention to Improve PrEP Uptake among Black Women.
    N Engl J Med 2024;390:776-777.
    


39. Lim SY, Lee J, Osuna CE, Vikhe P, et al.
    Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
    Science 2024.
    

Display articles in

• Abstract format
• Medline format